CLSI I/LA02
Quality Assurance of Laboratory Tests for Autoantibodies to Nuclear Antigens: (1) Indirect Fluorescence Assay for Microscopy and (2) Microtiter Enzyme Immunoassay Methods, 2nd Edition
This document addresses the criteria for ANA testing by immunofluorescence and by enzyme immunoassay, including test components, quantification of results, and classification criteria.
This document is available in electronic format only.
Member price:
List Price:Details
Chairholder: Marilyn M. Lightfoote, MD, PhD
Date of Publication: March 22, 2006
Order Code PDF: CLSI ILA02A2E
ISBN Number: 1-56238-601-8
Order Code Print: print not available
Edition: Second
Pages: 40
CLSI I/LA02 Additional Details
If interested in ordering larger quantities of this document in print, please contact us here.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
This document was formerly sold under the code DI10.
This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of September 2016. Because of its value to the laboratory community, it is being retained in CLSI’s library.